HK1005033A1 - Stable solutions of rebeccamycin analog and preparation thereof - Google Patents

Stable solutions of rebeccamycin analog and preparation thereof Download PDF

Info

Publication number
HK1005033A1
HK1005033A1 HK98104205A HK98104205A HK1005033A1 HK 1005033 A1 HK1005033 A1 HK 1005033A1 HK 98104205 A HK98104205 A HK 98104205A HK 98104205 A HK98104205 A HK 98104205A HK 1005033 A1 HK1005033 A1 HK 1005033A1
Authority
HK
Hong Kong
Prior art keywords
acid
rebeccamycin
diethylaminoethyl
water
recited
Prior art date
Application number
HK98104205A
Other languages
German (de)
English (en)
French (fr)
Chinese (zh)
Other versions
HK1005033B (en
Inventor
V. Venkataram Ubrani
K. Franchini Miriam
B. Bogardus Joseph
Original Assignee
Bristol-Myers Squibb Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol-Myers Squibb Company filed Critical Bristol-Myers Squibb Company
Publication of HK1005033B publication Critical patent/HK1005033B/en
Publication of HK1005033A1 publication Critical patent/HK1005033A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12Carboxylic acids; Salts or anhydrides thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Cephalosporin Compounds (AREA)
HK98104205A 1989-05-10 1998-05-15 Stable solutions of rebeccamycin analog and preparation thereof HK1005033A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US349608 1989-05-10
US07/349,608 US5496809A (en) 1989-05-10 1989-05-10 Stable solutions of rebeccamycin analog

Publications (2)

Publication Number Publication Date
HK1005033B HK1005033B (en) 1998-12-18
HK1005033A1 true HK1005033A1 (en) 1998-12-18

Family

ID=23373191

Family Applications (1)

Application Number Title Priority Date Filing Date
HK98104205A HK1005033A1 (en) 1989-05-10 1998-05-15 Stable solutions of rebeccamycin analog and preparation thereof

Country Status (25)

Country Link
US (1) US5496809A (cs)
EP (1) EP0397147B1 (cs)
JP (1) JPH0643437B2 (cs)
KR (1) KR920004098B1 (cs)
CN (1) CN1054510C (cs)
AT (1) ATE117313T1 (cs)
AU (1) AU618896B2 (cs)
CA (1) CA2015632C (cs)
CZ (1) CZ283416B6 (cs)
DE (1) DE69016087T2 (cs)
DK (1) DK0397147T3 (cs)
EG (1) EG19218A (cs)
ES (1) ES2066902T3 (cs)
FI (1) FI95777C (cs)
GR (1) GR3015714T3 (cs)
HK (1) HK1005033A1 (cs)
HU (1) HU206627B (cs)
IE (1) IE66515B1 (cs)
IL (1) IL94312A (cs)
NO (1) NO176390C (cs)
PT (1) PT93991B (cs)
RU (1) RU2053766C1 (cs)
TW (1) TW202390B (cs)
YU (1) YU90490A (cs)
ZA (1) ZA903535B (cs)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2130836A1 (en) * 1992-03-20 1993-09-30 Martin J. Slater Further indole derivatives with antiviral activity
US5968961A (en) * 1997-05-07 1999-10-19 Romark Laboratories, L.C. Pharmaceutical compositions of tizoxanide and nitazoxanide
AU5103898A (en) * 1996-11-05 1998-05-29 Alcon Laboratories, Inc. Polyhydroxy monocarboxylic and dicarboxylic acids and their lactones in ophthalmic compositions
US20040048012A1 (en) * 1996-11-18 2004-03-11 Weder Donald E. Polymeric materials having a matte finish on a surface thereof
CA2241609C (en) * 1997-06-26 2009-08-25 Southpac Trust International, Inc. Polymeric material having a cloth-like appearance
RU2185819C1 (ru) * 2001-10-18 2002-07-27 Дорофеенко Алла Ивановна Средство, обладающее противоопухолевым действием
RU2203056C1 (ru) * 2002-06-18 2003-04-27 Нестерук Владимир Викторович Способ получения твердой лекарственной формы препарата на основе дибазола
CN100344285C (zh) * 2005-02-03 2007-10-24 宋艳 多潘立酮水溶性制剂及其制备方法
JP4822151B2 (ja) * 2005-02-14 2011-11-24 山本光学株式会社 眼鏡保持バンドおよびその保持バンド付き眼鏡

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4785085A (en) * 1986-11-21 1988-11-15 Bristol-Myers Company Rebeccamycin analogs
US4808613A (en) * 1986-11-21 1989-02-28 Bristol-Myers Company Rebeccamycin derivative containing pharmaceutical composition

Also Published As

Publication number Publication date
PT93991A (pt) 1991-02-08
EP0397147B1 (en) 1995-01-18
CN1047204A (zh) 1990-11-28
PT93991B (pt) 1996-11-29
FI95777B (fi) 1995-12-15
EP0397147A3 (en) 1991-06-12
NO176390B (no) 1994-12-19
IE901687L (en) 1990-11-10
IL94312A (en) 1994-02-27
ZA903535B (en) 1991-01-30
FI95777C (fi) 1996-03-25
AU5482390A (en) 1990-11-15
CZ225590A3 (en) 1997-12-17
ATE117313T1 (de) 1995-02-15
RU2053766C1 (ru) 1996-02-10
HU206627B (en) 1992-12-28
IE66515B1 (en) 1996-01-10
CZ283416B6 (cs) 1998-04-15
DK0397147T3 (da) 1995-03-20
EG19218A (en) 1994-10-30
DE69016087D1 (de) 1995-03-02
NO902048L (no) 1990-11-12
IL94312A0 (en) 1991-03-10
ES2066902T3 (es) 1995-03-16
TW202390B (cs) 1993-03-21
NO176390C (no) 1995-03-29
US5496809A (en) 1996-03-05
EP0397147A2 (en) 1990-11-14
CA2015632C (en) 1998-01-27
HU902989D0 (en) 1990-09-28
KR900017596A (ko) 1990-12-19
FI902276A0 (fi) 1990-05-07
HUT54053A (en) 1991-01-28
KR920004098B1 (ko) 1992-05-25
GR3015714T3 (en) 1995-07-31
YU90490A (en) 1991-10-31
DE69016087T2 (de) 1995-05-24
CA2015632A1 (en) 1990-11-10
AU618896B2 (en) 1992-01-09
JPH0643437B2 (ja) 1994-06-08
CN1054510C (zh) 2000-07-19
NO902048D0 (no) 1990-05-09
JPH0317094A (ja) 1991-01-25

Similar Documents

Publication Publication Date Title
EP0216459B1 (en) 9-substituted guanine monohydrates
EP0401895A1 (en) Aqueous folinate solution stable at refrigerator temperature, as well as process for its preparation
NO314727B1 (no) Krystallinsk, vannfritt mykofenolatmofetil, intravenöst preparat derav, fremgangsmåter for fremstilling av preparat og formulering,anvendelse av forbindelsen til fremstilling av et medikament, samt sett anvendelig forfremstilling avintravenös
EP0397147B1 (en) Stable solutions of rebeccamycin analog and preparation thereof
BG106589A (bg) Фармацевтични разтвори от левосимендан
US4673666A (en) 2-amino-3-ethoxycarbonylamino-6-(p-fluoro-benzylamino)-pyridine gluconate and pharmaceutical preparations containing it
HK1005033B (en) Stable solutions of rebeccamycin analog and preparation thereof
WO2020196814A1 (en) Benzoazepine compound-containing freeze-dried composition
JPH0525857B2 (cs)
US4360523A (en) Pharmaceutical formulations of 4'-(9-acridinylamino)-methanesulfon-m-anisidide
US4696814A (en) Parenteral phenytoin compositions
US4889862A (en) Freeze-dried pharmaceutical compositions of phenylquinoline carboxylic acids
CZ293433B6 (cs) Lyofilizované thioxantenonové protinádorové látky
HU191538B (en) Process for producing pharmaceutical compositions containing acid additional salts of vinca-dimeres
US4966899A (en) Antibacterial lyophilized preparation of aspoxicillin
KR920006911B1 (ko) 안정한 피록시캄 주사액 조성물 및 그의 제조방법
US4425348A (en) Antitumor compositions
US3253990A (en) N-methyl glucammonium salicylate and uses therefor
US4322424A (en) Crystalline glucoconate salt of m-AMSA and compositions containing same
US4663458A (en) Water soluble salt composition of m-AMSA
US4450161A (en) Pyrimidone salt and its preparation
US4946689A (en) Concentrated, stabilized cis-diamminedinitratoplatinum solutions for conversion to cisplatin
WO2023237485A1 (en) Stable lyophilisates comprising 5,10-methylene-(6r)-tetrahydrofolic acid
EP0369714A1 (en) Cisplatin hypertonic solution
EP0880966A1 (en) Thiamine disulfides and medicines containing the same as the active ingredient

Legal Events

Date Code Title Description
PF Patent in force
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20070509